USE OF CARDIOVASCULAR RISK REDUCTION THERAPIES IN PATIENTS WITH TYPE 2 DIABETES AND ESTABLISHED ATHEROSCLEROTIC CARDIOVASCULAR DISEASE — THE HOUSTON METHODIST HOSPITAL.

Authors :: Taha, Mohamad B.
Bose, Budhaditya
Lahan, Shubham
Khan, Safi
Sharma, Garima
Soliman, Ahmed
Bhimaraj, Arvind
Patel, Kershaw
Cainzos-Achirica, Miguel
Nasir, Khurram
Source :: Journal of the American College of Cardiology (JACC). 2023 Supplement, Vol. 81, p1775-1775. 1p.
Publication Year :: 2023

Subjects :: *TYPE 2 diabetes
*CARDIOVASCULAR diseases risk factors
*CARDIOVASCULAR diseases
*METHODISTS
*HOSPITALS

Full Text Access

Tools